Immix Biopharma annual operating expenses
2020
2021
2022
2023
2024
2025
Immix Biopharma Operating Expenses Growth & History (IMMX)
Immix Biopharma's operating expenses was $30.0M for fiscal 2025.
View full Immix Biopharma company overviewImmix Biopharma annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $30.0M | $7.3M | +32.11% |
| 2024 | 2024-12-31 | $22.7M | $6.5M | +40.48% |
| 2023 | 2023-12-31 | $16.1M | $7.9M | +96.39% |
| 2022 | 2022-12-31 | $8.2M | $6.9M | +507.90% |
| 2021 | 2021-12-31 | $1.4M | $898,162 | +197.90% |
| 2020 | 2020-12-31 | $453,852 | — | — |
Immix Biopharma quarterly operating expenses
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $12.5M | $5.7M | +85.43% |
| Q1 2026 | 2026-03-31 | $10.8M | $6.1M | +130.71% |
| Q4 2025 | 2025-12-31 | $10.9M | $5.9M | +118.43% |
| Q3 2025 | 2025-09-30 | $7.7M | $267,578 | +3.62% |
| Q2 2025 | 2025-06-30 | $6.7M | $2.0M | +42.85% |
| Q1 2025 | 2025-03-31 | $4.7M | −$907,208 | −16.23% |
| Q4 2024 | 2024-12-31 | $5.0M | −$388,732 | −7.23% |
| Q3 2024 | 2024-09-30 | $7.4M | $2.9M | +63.47% |
| Q2 2024 | 2024-06-30 | $4.7M | $981,785 | +26.39% |
| Q1 2024 | 2024-03-31 | $5.6M | $3.1M | +121.76% |
| Q4 2023 | 2023-12-31 | $5.4M | $1.6M | +41.67% |
| Q3 2023 | 2023-09-30 | $4.5M | $3.0M | +195.02% |
| Q2 2023 | 2023-06-30 | $3.7M | $2.2M | +138.36% |
| Q1 2023 | 2023-03-31 | $2.5M | $1.2M | +89.52% |
| Q4 2022 | 2022-12-31 | $3.8M | $3.2M | +534.19% |
| Q3 2022 | 2022-09-30 | $1.5M | $1.2M | +340.64% |
| Q2 2022 | 2022-06-30 | $1.6M | $1.3M | +541.93% |
| Q1 2022 | 2022-03-31 | $1.3M | $1.2M | +718.38% |
| Q4 2021 | 2021-12-31 | $598,338 | — | — |
| Q3 2021 | 2021-09-30 | $347,991 | — | — |
| Q2 2021 | 2021-06-30 | $243,165 | — | — |
| Q1 2021 | 2021-03-31 | $162,520 | — | — |
Immix Biopharma operating expenses trends
Over the last five fiscal years, Immix Biopharma's operating expenses increased from $453,852 to $30.0M, a change of $29.5M. The latest reported quarter, Q2 2026, shows $12.5M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Immix Biopharma source filings ↗